Dr. Bruce M. Nakfoor Jr., MD

Dr. Nakfoor practices at Advocate Radiation Oncology in Port Charlotte, Florida.

Dr. Nakfoor's NPI, 1780687608, was assigned on May 24, 2005. Dr. Nakfoor graduated from University Of Michigan Medical School in 1991. Dr. Nakfoor holds Florida license ME0070717.

Dr. Nakfoor's primary practice is Advocate Radiation Oncology, at 3080 Harbor Blvd, Port Charlotte, FL 33952 in Charlotte County. The practice phone is (941) 883-2199.

Dr. Nakfoor's primary practice is Advocate Radiation Oncology in Port Charlotte, Florida. Dr. Nakfoor is also affiliated with Lee Memorial Hospital. The medical group on file is Advocate Radiation Oncology. Dmand AI also links Dr. Nakfoor to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nakfoor practices, 4 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Nakfoor's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Nakfoor is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Nakfoor's licenses on file in 4 states: Florida, New York, Nevada and Michigan.

Dmand AI lists anal cancer radiation, bladder cancer radiation, bone cancer radiation, brain cancer radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation and head & neck cancer radiation among the conditions Dr. Nakfoor treats.

CMS data shows 6,559 Medicare services from Dr. Nakfoor across 24 procedure codes in 2024, for 742 Medicare patients. Medicare paid $1,277,451 for them. Every service was in an office.

CMS counts 742 Medicare patients who saw Dr. Nakfoor in 2024. The largest group is 75 to 84, with 367 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nakfoor's median patient age at 77, with 36% women.

In 2024, Dr. Nakfoor wrote 108 Medicare Part D claims for 58 patients. 90% of them were for generic drugs. CMS names the drug for 29 of them, across 2 drugs with 11 or more claims each, at $212 in total drug cost. In 2023, CMS named 25 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Nakfoor for performance year 2024, reported individually. Dr. Nakfoor accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 12 papers to Dr. Nakfoor, published from 2005 to 2021. The most frequent topics are Radiotherapy Dosage, Carcinoma, Squamous Cell and Laryngeal Neoplasms. Dr. Nakfoor has published most often in Cancer J Sci Am. Dr. Nakfoor's most frequent co-authors are Daniel E. Dosoretz, MD, Michael J. Katin, MD and Constantine A. Mantz, MD.

CMS Open Payments shows 5 general payments to Dr. Nakfoor from 5 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Augmenix, Inc. paid the most, $137.

Dmand AI lists 2 awards for Dr. Nakfoor, most recently Gulfshore Life Magazine: Top Doctors in 2019.

Dr. Nakfoor graduated from University Of Michigan Medical School in 1991.

Dr. Nakfoor is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.